Table of Contents Author Guidelines Submit a Manuscript
International Journal of Genomics
Volume 2015, Article ID 197603, 9 pages
http://dx.doi.org/10.1155/2015/197603
Research Article

Exploring the Functional Disorder and Corresponding Key Transcription Factors in Intraductal Papillary Mucinous Neoplasms Progression

1Department of Oncology, Tianjin Third Central Hospital, Tianjin 300179, China
2Key Laboratory of Artificial Cell Institute of Hepatobiliary Disease, Tianjin Third Central Hospital, Tianjin 300179, China
3Department of Hepatobiliary Surgery, Tianjin Third Central Hospital, Tianjin 300179, China

Received 18 June 2015; Accepted 11 August 2015

Academic Editor: Giulia Piaggio

Copyright © 2015 Guiying Bai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Distler, D. Aust, J. Weitz, C. Pilarsky, and R. Grützmann, “Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN,” BioMed Research International, vol. 2014, Article ID 474905, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. F. T. Bosman, F. Carneiro, R. H. Hruban, and N. Thise, Classifiation of Tumours of the Digestive System, WHO, Lyon, France, 2010.
  3. M. Distler, S. Kersting, M. Niedergethmann et al., “Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas,” Annals of Surgery, vol. 258, no. 2, pp. 324–330, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Furukawa, G. Klöppel, N. V. Adsay et al., “Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study,” Virchows Archiv, vol. 447, no. 5, pp. 794–799, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Z'graggen, J. A. Rivera, C. C. Compton et al., “Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas,” Annals of Surgery, vol. 226, no. 4, pp. 491–500, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Sessa, E. Solcia, C. Capella et al., “Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients,” Virchows Archiv, vol. 425, no. 4, pp. 357–367, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Wu, H. Matthaei, A. Maitra et al., “Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development,” Science Translational Medicine, vol. 3, no. 92, Article ID 92ra66, 2001. View at Google Scholar
  8. J. Wu, Y. Jiao, M. Dal Molin et al., “Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 52, pp. 21188–21193, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. P. S. Moore, S. Orlandini, G. Zamboni et al., “Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis,” British Journal of Cancer, vol. 84, no. 2, pp. 253–262, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Jiang, W. Zang, L. Wang, Y. Xu, Y. Liu, and S.-X. Deng, “Protein-protein interaction and SNP analysis in intraductal papillary mucinous neoplasm,” Gene, vol. 513, no. 1, pp. 219–224, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Tanaka, T. Kuroki, T. Adachi et al., “Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm,” Pancreas, vol. 42, no. 3, pp. 488–493, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. O. Basturk, S. Khayyata, D. S. Klimstra et al., “Preferential expression of MUC6 in oncocytic and pancreatobiliary types of intraductal papillary neoplasms highlights a pyloropancreatic pathway, distinct from the intestinal pathway, in pancreatic carcinogenesis,” American Journal of Surgical Pathology, vol. 34, no. 3, pp. 364–370, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Semba, T. Moriya, W. Kimura, and M. Yamakawa, “Phosphorylated Akt/PKB controls cell growth and apoptosis in intraductal papillary-mucinous tumor and invasive ductal adenocarcinoma of the pancreas,” Pancreas, vol. 26, no. 3, pp. 250–257, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Miyasaka, E. Nagai, H. Yamaguchi et al., “The role of the DNA damage checkpoint pathway in intraductal papillary mucinous neoplasms of the pancreas,” Clinical Cancer Research, vol. 13, no. 15, pp. 4371–4377, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Furukawa, R. Fujisaki, Y. Yoshida et al., “Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas,” Modern Pathology, vol. 18, no. 8, pp. 1034–1042, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Kitago, M. Ueda, K. Aiura et al., “Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas,” International Journal of Cancer, vol. 110, no. 2, pp. 177–182, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Hiraoka, R. Yamazakiitoh, Y. Ino et al., “CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis,” Gastroenterology, vol. 140, no. 1, pp. 310–321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. P. A. Futreal, L. Coin, M. Marshall et al., “A census of human cancer genes,” Nature Reviews Cancer, vol. 4, no. 3, pp. 177–183, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources,” Nature Protocols, vol. 4, no. 1, pp. 44–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Gama-Castro, V. Jiménez-Jacinto, M. Peralta-Gil et al., “RegulonDB (version 6.0): gene regulation model of Escherichia coli K-12 beyond transcription, active (experimental) annotated promoters and Textpresso navigation,” Nucleic Acids Research, vol. 36, no. 1, pp. D120–D124, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Gong, R. Wu, Y. Zhang et al., “Extracting consistent knowledge from highly inconsistent cancer gene data sources,” BMC Bioinformatics, vol. 11, article 76, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Ma, D. Yang, Y. Gu, X. Guo, W. Zhao, and Z. Guo, “Finding disease-specific coordinated functions by multi-function genes: insight into the coordination mechanisms in diseases,” Genomics, vol. 94, no. 2, pp. 94–100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. P. Di Magliano and C. D. Logsdon, “Roles for KRAS in pancreatic tumor development and progression,” Gastroenterology, vol. 144, no. 6, pp. 1220–1229, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Huang, W.-M. Wang, J.-P. Gong, and K. Yang, “Oncogenesis and the clinical significance of K-ras in pancreatic adenocarcinoma,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 5, pp. 2699–2701, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. J. B. Greer and D. C. Whitcomb, “Role of BRCA1 and BRCA2 mutations in pancreatic cancer,” Gut, vol. 56, no. 5, pp. 601–605, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. J. K. Choi, U. Yu, O. J. Yoo, and S. Kim, “Differential coexpression analysis using microarray data and its application to human cancer,” Bioinformatics, vol. 21, no. 24, pp. 4348–4355, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Breeze, E. Harrison, S. McHattie et al., “High-resolution temporal profiling of transcripts during Arabidopsis leaf senescence reveals a distinct chronology of processes and regulation,” Plant Cell, vol. 23, no. 3, pp. 873–894, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. Z. Chen, W. Holland, J. M. Shelton et al., “Mutation of mouse Samd4 causes leanness, myopathy, uncoupled mitochondrial respiration, and dysregulated mTORC1 signaling,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 20, pp. 7367–7372, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. C. V. Dang, “MYC, metabolism, cell growth, and tumorigenesis,” Cold Sspring harbor perspectives in medicine, vol. 3, no. 8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Tachibana, D. Yamasaki, K. Ishimoto, and T. Doi, “The role of PPARs in cancer,” PPAR Research, vol. 2008, Article ID 102737, 15 pages, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. N. V. Adsay, K. Merati, A. Andea et al., “The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis,” Modern Pathology, vol. 15, no. 10, pp. 1087–1095, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. W.-Q. Chen, D. Liang, S.-W. Zhang, R.-S. Zheng, and Y.-T. He, “Pancreatic cancer incidence and mortality patterns in China, 2009,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 12, pp. 7321–7324, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. S. T. Chari, D. Yadav, T. C. Smyrk et al., “Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas,” Gastroenterology, vol. 123, no. 5, pp. 1500–1507, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Nakagohri, M. Konishi, K. Inoue, Y. Tanizawa, and T. Kinoshita, “Invasive carcinoma derived from intraductal papillary mucinous carcinoma of the pancreas,” Hepato-Gastroenterology, vol. 51, no. 59, pp. 1480–1483, 2004. View at Google Scholar · View at Scopus
  35. G. Cheng, J. Zielonka, D. McAllister, S. Tsai, M. B. Dwinell, and B. Kalyanaraman, “Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation,” British Journal of Cancer, vol. 111, no. 1, pp. 85–93, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Ohmine, K. Kawaguchi, S. Ohtsuki et al., “Attenuation of phosphorylation by deoxycytidine kinase is key to acquired gemcitabine resistance in a pancreatic cancer cell line: targeted proteomic and metabolomic analyses in PK9 cells,” Pharmaceutical Research, vol. 29, no. 7, pp. 2006–2016, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Bardeesy and R. A. DePinho, “Pancreatic cancer biology and genetics,” Nature Reviews Cancer, vol. 2, no. 12, pp. 897–909, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. E. A. Kruse, S. J. Loughran, T. M. Baldwin et al., “Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 33, pp. 13814–13819, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. D. L. Stockman, J. L. Hornick, M. T. Deavers, D. C. Lev, A. J. Lazar, and W.-L. Wang, “ERG and FLI1 protein expression in epithelioid sarcoma,” Modern Pathology, vol. 27, no. 4, pp. 496–501, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. D. R. Robinson, Y.-M. Wu, P. Vats et al., “Activating ESR1 mutations in hormone-resistant metastatic breast cancer,” Nature Genetics, vol. 45, no. 12, pp. 1446–1451, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. J. K. Thomas, M.-S. Kim, L. Balakrishnan et al., “Pancreatic Cancer Database: an integrative resource for pancreatic cancer,” Cancer Biology and Therapy, vol. 15, no. 8, pp. 963–967, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. L. M. Hix, J. Karavitis, M. W. Khan, Y. H. Shi, K. Khazaie, and M. Zhang, “Tumor STAT1 transcription factor activity enhances breast tumor growth and immune suppression mediated by myeloid-derived suppressor cells,” Journal of Biological Chemistry, vol. 288, no. 17, pp. 11676–11688, 2013. View at Publisher · View at Google Scholar · View at Scopus